TAD Pharma Overview

  • Founded
  • 1968
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 247
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

TAD Pharma General Information

Description

Manufacturer of generic pharmaceutical products. The company focuses on drugs for cardiovascular, central nervous system and urogenital diseases.

Contact Information

Website
www.tad.de
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Krka
Primary Office
  • Heinz-Lohmann-Straße 5
  • 27472 Cuxhaven
  • Germany
+49 04721 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TAD Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TAD Pharma‘s full profile, request access.

Request a free trial

TAD Pharma Patents

  • 8

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

TAD Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-10101962-A1 Dna sequence with regulatory areas for the expression of proteins Granted 17-Jan-2001 00000000 0
JP-2004519239-A Dna sequence containing regulatory region for protein expression Granted 17-Jan-2001 00000000
DE-10101962-B4 Dna sequence with regulatory regions for the expression of proteins Expired - Fee Related 17-Jan-2001 000000000 0
CA-2436815-A1 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins Abandoned 17-Jan-2001 000000000
US-20040161841-A1 Vector coding triosephosphate isomerase and heterologous nucleotide sequences for use in producing genetic vaccines; bioreactors Abandoned 17-Jan-2001 C12N9/90 0

TAD Pharma Executive Team (2)

Name Title Board Seat Contact Info
Jens-Peter Schutz General Manager
You’re viewing 1 of 2 executive team members. Get the full list »

TAD Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial